The effect of different concentrations of ropivacaine on caudal block in children with circumcision

Status

Active, not recruiting

Phases

Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000040244

Enrollment

Unknown

Registered

2020-11-26

Start date

2020-11-25

Completion date

Unknown

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

children undergoing circumcision

Interventions

P1 group:0.25% ropivacaine:0.25% ropivacaine injected

P2 group:0.2% ropivacaine:0.2% ropivacaine injected

P3 group:0.15% ropivacaine:0.15% ropivacaine injected

Eligibility

Sex/Gender

Male

Age

6 Years to 12 Years

Inclusion criteria

Inclusion criteria: 1 ASA (American Society of Anesthesiology) grade =II, age 6 to 12 years old, school-age children with pericarpium ligation. 2. Children without coagulation dysfunction, puncture site without infection and other contraindications of caudal block.

Exclusion criteria

Exclusion criteria: 1. Children with failed operation or unclear effect of caudal block. 2. Children with temporary intraoperative change of operation method. 3. Children with long-term anesthetic and analgesic drugs added during operation.

Design outcomes

Primary

Measure	Time frame
success rate of caudal block;	—

Secondary

Measure	Time frame
duration of block efficacy;	—

Countries

China

Contacts

Public Contactzhang bin

qletyymzk@sina.com18866115706

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026